-
BBP Dashboard
- Holdings
Virtus LifeSci Biotech Products ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
TVTX Travere Therapeutics, Inc. | 796.08 k | 45.49 k shares | 3.60 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 548.64 k | 2.06 k shares | 2.48 | Common equity | Long | USA |
PHAT Phathom Pharmaceuticals, Inc. | 515.84 k | 30.08 k shares | 2.33 | Common equity | Long | USA |
ZLAB Zai Lab Limited | 505.49 k | 16.73 k shares | 2.28 | Common equity | Long | China |
ADMA ADMA Biologics, Inc. | 498.30 k | 30.55 k shares | 2.25 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 497.93 k | 15.00 k shares | 2.25 | Common equity | Long | USA |
TGTX TG Therapeutics, Inc. | 492.45 k | 19.65 k shares | 2.22 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 474.75 k | 12.34 k shares | 2.14 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 460.27 k | 5.18 k shares | 2.08 | Common equity | Long | USA |
AUPH Aurinia Pharmaceuticals Inc. | 443.85 k | 61.56 k shares | 2.00 | Common equity | Long | Canada |
TARS Tarsus Pharmaceuticals, Inc. | 442.14 k | 9.94 k shares | 2.00 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 428.20 k | 1.15 k shares | 1.93 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals Incorporated | 427.98 k | 4.05 k shares | 1.93 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 423.45 k | 52.87 k shares | 1.91 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 407.99 k | 4.81 k shares | 1.84 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 407.88 k | 39.07 k shares | 1.84 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 404.37 k | 4.54 k shares | 1.83 | Common equity | Long | USA |
BGNE BeiGene, Ltd. | 401.02 k | 1.98 k shares | 1.81 | Common equity | Long | USA |
KNSA Kiniksa Pharmaceuticals, Ltd. | 396.59 k | 17.56 k shares | 1.79 | Common equity | Long | USA |
YMAB Y-mAbs Therapeutics, Inc. | 396.59 k | 27.33 k shares | 1.79 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 389.46 k | 7.64 k shares | 1.76 | Common equity | Long | USA |
INCY Incyte Corporation | 389.43 k | 5.25 k shares | 1.76 | Common equity | Long | USA |
BNTX BioNTech SE | 388.05 k | 3.43 k shares | 1.75 | Common equity | Long | Germany |
DAWN Day One Biopharmaceuticals, Inc. | 375.23 k | 25.49 k shares | 1.69 | Common equity | Long | USA |
INSM Insmed Incorporated | 359.54 k | 5.34 k shares | 1.62 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 356.29 k | 8.93 k shares | 1.61 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings, Inc. | 355.58 k | 11.07 k shares | 1.61 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 354.30 k | 7.42 k shares | 1.60 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 353.32 k | 30.94 k shares | 1.60 | Common equity | Long | USA |
AMGN Amgen Inc. | 353.14 k | 1.10 k shares | 1.60 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd. | 351.89 k | 30.47 k shares | 1.59 | Common equity | Long | USA |
LXRX Lexicon Pharmaceuticals, Inc. | 350.95 k | 179.97 k shares | 1.59 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 339.54 k | 7.54 k shares | 1.53 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 335.63 k | 6.64 k shares | 1.52 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 332.01 k | 2.64 k shares | 1.50 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 327.47 k | 688.00 shares | 1.48 | Common equity | Long | USA |
DREYFUS GOVERNMENT CASH MANAGE | 325.42 k | 325.42 k shares | 1.47 | Short-term investment vehicle | Long | USA |
DVAX Dynavax Technologies Corporation | 324.96 k | 27.42 k shares | 1.47 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 318.44 k | 21.83 k shares | 1.44 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 316.38 k | 2.58 k shares | 1.43 | Common equity | Long | Denmark |
TBPH Theravance Biopharma, Inc. | 316.30 k | 38.39 k shares | 1.43 | Common equity | Long | Cayman Islands |
AGIO Agios Pharmaceuticals, Inc. | 312.88 k | 7.04 k shares | 1.41 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 310.90 k | 1.80 k shares | 1.40 | Common equity | Long | USA |
Madrigal Pharmaceuticals, Inc. | 308.36 k | 1.19 k shares | 1.39 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 307.47 k | 8.01 k shares | 1.39 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 297.88 k | 50.75 k shares | 1.35 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 292.32 k | 56.11 k shares | 1.32 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 290.69 k | 2.42 k shares | 1.31 | Common equity | Long | USA |
GERN Geron Corporation | 277.38 k | 67.49 k shares | 1.25 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 270.93 k | 3.10 k shares | 1.22 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 269.06 k | 321.00 shares | 1.22 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 265.87 k | 11.36 k shares | 1.20 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 257.63 k | 3.91 k shares | 1.16 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 255.83 k | 8.30 k shares | 1.16 | Common equity | Long | UK |
SWTX SpringWorks Therapeutics, Inc. | 253.54 k | 8.41 k shares | 1.15 | Common equity | Long | USA |
BIIB Biogen Inc. | 244.99 k | 1.41 k shares | 1.11 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 234.13 k | 5.05 k shares | 1.06 | Common equity | Long | Switzerland |
ESPR Esperion Therapeutics, Inc. | 230.88 k | 113.18 k shares | 1.04 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 217.55 k | 55.08 k shares | 0.98 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 210.94 k | 7.74 k shares | 0.95 | Common equity | Long | USA |
NVAX Novavax, Inc. | 210.31 k | 21.88 k shares | 0.95 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 174.13 k | 28.64 k shares | 0.79 | Common equity | Long | USA |
MRNA Moderna, Inc. | 123.29 k | 2.27 k shares | 0.56 | Common equity | Long | USA |
OABI OmniAb, Inc. | 0 | 1.30 k shares | 0.00 | Common equity | Long | USA |
OABI OmniAb, Inc. | 0 | 1.30 k shares | 0.00 | Common equity | Long | USA |